Linden Thomas Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.12M | Buy |
12,638
+7,241
| +134% | +$2.94M | 0.56% | 31 |
|
|
2025
Q1 | $2.69M | Buy |
5,397
+651
| +14% | +$324K | 0.35% | 76 |
|
|
2024
Q4 | $2.47M | Buy |
4,746
+569
| +14% | +$296K | 0.31% | 86 |
|
|
2024
Q3 | $2.58M | Buy |
4,177
+701
| +20% | +$434K | 0.35% | 70 |
|
|
2024
Q2 | $1.92M | Buy |
3,476
+593
| +21% | +$328K | 0.3% | 101 |
|
|
2024
Q1 | $1.68M | Buy |
2,883
+1,099
| +62% | +$639K | 0.27% | 133 |
|
|
2023
Q4 | $947K | Buy |
1,784
+238
| +15% | +$126K | 0.18% | 239 |
|
|
2023
Q3 | $783K | Buy |
1,546
+125
| +9% | +$63.3K | 0.17% | 254 |
|
|
2023
Q2 | $741K | Buy |
1,421
+225
| +19% | +$117K | 0.16% | 251 |
|
|
2023
Q1 | $689K | Buy |
1,196
+382
| +47% | +$220K | 0.17% | 235 |
|
|
2022
Q4 | $448K | Buy |
+814
| New | +$448K | 0.13% | 262 |
|